BiotechTubeBiotechTube
Home/Erasca/Yifah Yaron, M.D., Ph.D.
YY

Yifah Yaron, M.D., Ph.D.

Vice President of Clinical Development

Erasca

Therapeutic Areas

OncologyPrecision Oncology

Erasca Pipeline

DrugIndicationPhase
ERAS-0015RASm solid tumorsPhase 1
ERAS-4001KRASm solid tumorsPhase 1
ERAS-007RAS/MAPK-altered solid tumorsPhase 1b/2
ERAS-601RAS/MAPK-altered solid tumorsPhase 1
ERAS-801Recurrent Glioblastoma (GBM)Phase 1
ERAS-1KRAS G12C-mutant tumorsDiscovery
ERAS-4KRAS G12D-mutant tumorsDiscovery
ERAS-9RAS/MAPK-altered tumorsDiscovery

Leadership Team at Erasca

JE
Jonathan E. Lim, M.D.
Chairman, CEO and Co-founder
MV
Michael Varney, Ph.D.
Chair of R&D, SAB Member and Board Director
DC
David Chacko, M.D.
Chief Financial Officer and Chief Business Officer
NC
Nik Chetwyn, Ph.D.
Chief Operating Officer
EG
Ebun Garner, J.D.
Chief Legal Officer
CL
Chandra Lovejoy
Chief Regulatory Affairs Officer
SM
Shannon Morris, M.D., Ph.D.
Chief Medical Officer
RS
Robert Shoemaker, Ph.D.
Chief Scientific Officer
LT
Lisa Tesvich-Bonora, Ph.D.
Chief People Officer
BB
Brian Baker, CPA
Senior Vice President of Finance
View full Erasca profile